Cargando…
Humoral Response to SARS-CoV-2 Vaccine of a Patient Receiving Methotrexate Treatment and Implications for the Need of Monitoring
We report a case of monitoring the antibody response to the BioNTech–Pfizer vaccine of a 50-year-old female diagnosed with rheumatoid arthritis undergoing treatment with methotrexate (MTX). Antibody levels were measured 21 days after dose 1 (i.e., on the day of dose 2) and then 8, 14 and 30 days aft...
Autores principales: | Lukaszuk, Krzysztof, Woclawek-Potocka, Izabela, Jakiel, Grzegorz, Malinowska, Paulina, Wdowiak, Artur, Rozanska, Karolina, Rabalski, Lukasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541181/ https://www.ncbi.nlm.nih.gov/pubmed/34696259 http://dx.doi.org/10.3390/vaccines9101151 |
Ejemplares similares
-
Usefulness of IVD Kits for the Assessment of SARS-CoV-2 Antibodies to Evaluate the Humoral Response to Vaccination
por: Lukaszuk, Krzysztof, et al.
Publicado: (2021) -
Humoral Response after Vaccination with Half-Dose of BNT162b2 in Subjects under 55 Years of Age
por: Lukaszuk, Krzysztof, et al.
Publicado: (2021) -
IMSI—Guidelines for Sperm Quality Assessment
por: Lukaszuk, Krzysztof, et al.
Publicado: (2022) -
Inflammation-Related Molecules at the Maternal–Fetal Interface during Pregnancy and in Pathologically Altered Endometrium
por: Sieg, Wlodzimierz, et al.
Publicado: (2022) -
Decreasing Quality of the New Generations of Anti-Müllerian Hormone Assays
por: Lukaszuk, Krzysztof, et al.
Publicado: (2014)